A Reply to ''Evidence that STK19 Is Not an NRAS-Dependent Melanoma Driver".

Yin, Chengqian; Zhu, Bo; Li, Xin; Goding, Colin R; Cui, Rutao

Yin, Chengqian; Zhu, Bo; Li, Xin; Goding, Colin R; Cui, Rutao.

Afiliación

Yin C; Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: yincq323@gmail.com.
Zhu B; Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA.
Li X; Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA.
Goding CR; Ludwig Institute for Cancer Research, University of Oxford, Headington, Oxford OX3 7DQ, UK.
Cui R; Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: rutaocui@bu.edu.

Cell ; 181(6): 1406-1409.e2, 2020 06 11.

Article en En | MEDLINE | ID: mdl-32531246

Asunto(s)

Melanoma; GTP Fosfohidrolasas/genética; Humanos; Melanoma/genética; Proteínas de la Membrana/genética; Proteínas Nucleares; Proteínas Serina-Treonina Quinasas

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Melanoma Límite: Humans Idioma: En Revista: Cell Año: 2020 Tipo del documento: Article